查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1799074

全球疫苗物流市场

Vaccine Logistics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 269 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计2030年全球疫苗物流市场规模将达38亿美元

全球疫苗物流市场规模预计在2024年为30亿美元，预计到2030年将达到38亿美元，2024年至2030年的复合年增长率为4.0%。运输服务是本报告分析的细分市场之一，预计其复合年增长率为3.8%，到分析期结束时规模将达到22亿美元。仓储服务细分市场在分析期间的复合年增长率预计为4.5%。

美国市场预计将达到 8.267 亿美元，而中国市场预计将以 7.3% 的复合年增长率成长

美国疫苗物流市场规模预计2024年达到8.267亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到7.789亿美元，在2024-2030年的分析期间内，复合年增长率为7.3%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为1.6%和3.2%。在欧洲，预计德国市场的复合年增长率为2.3%。

全球疫苗物流市场－主要趋势与驱动因素摘要

与其他低温运输市场相比，疫苗物流为何显得特别复杂？

疫苗物流在低温运输物流产业中占据独特的地位，需要超可靠的温度控制、时效性强的配送以及跨区域的监管可追溯性。与典型的药品和易生鲜产品不同，疫苗属于生技药品，其温度阈值要求较低（通常为 2°C 至 8°C），在某些情况下（例如 mRNA 疫苗），甚至需要在 -70°C 的温度下冷冻运输。从最初一英里的生产、中间一英里的空运/海运，到最后一英里送达诊所和疫苗接种中心，都必须持续保持这些条件。即使是轻微的温度异常也可能导致疫苗无法使用，造成健康风险、法规不合规和经济损失。

新冠疫苗的推广暴露了疫苗物流的规模和复杂性，刺激了对超低温冷冻库、物联网热包装和视觉化软体的投资。不仅是疫情，各国政府、联合国儿童基金会和全球疫苗免疫联盟管理的常规免疫计画每年也需要向偏远和服务欠缺地区运送数十亿剂疫苗。这需要专门的热包装（相变材料、真空隔热板）、被动冷却箱和多模态协调。其他挑战包括管理未使用或过期疫苗的逆向物流、简化通关流程以及与世界卫生组织协调国家免疫计画。

哪些技术将改变疫苗运输和储存的未来？

数位供应链平台、即时状态监控和人工智慧路线规划正在改变疫苗物流。疫苗包装和运输容器中嵌入的互联感测器技术可即时监测温度、湿度、振动和光照。这些感测器透过蓝牙或行动电话网路将资料传输到云端基础仪表板，从而实现主动风险规避。医药物流供应商现在正在使用人工智慧演算法来预测瓶颈、优化配送时间，并根据天气或地缘政治动盪情况调整货运。

另一项创新是利用无人机物流和电动车（EV）在偏远地区和拥塞都市区进行最后一哩配送。太阳能冷藏箱和可携式疫苗冰箱也在非通电地区部署。数据分析正在改善预测和库存计划，减少缺货和疫苗浪费。区块链实验正在探索，以实现对疫苗来源、批次记录和监管审核线索的防篡改追踪。这些数位层面对于建立信任至关重要，尤其是在监管往往缺乏协调的国际疫苗交易中。

哪里对专业化疫苗物流的需求成长最快？

受免疫接种计画扩大、成人疫苗接种率上升以及疫情防治工作的推动，已开发市场和新兴市场对专业疫苗物流的需求都在激增。高所得国家正致力于建造季节性流感、呼吸道合胞病毒、带状疱疹和新冠肺炎加强剂的弹性低温运输。这些地区也正在投资智慧仓库、温控配送中心以及疫苗製造商、经销商和公共卫生系统之间的API整合。

中低收入国家 (LMIC) 高度重视「最后一哩路」覆盖、低温运输电气化以及加强公私物流伙伴关係。诸如全球疫苗接种计划 (COVAX)、全球疫苗和免疫联盟 (Gavi) 的冷链设备优化平台 (CCEOP) 以及帕斯健康科技 (PATH) 的下一代低温运输解决方案等全球卫生倡议正在推动太阳能冰箱、数位疫苗管瓶监测器 (VVM) 和医护人员培训的普及。撒哈拉以南非洲、东南亚和拉丁美洲的国家也正在采用国家疫苗物流管理系统 (vLMIS) 来追踪疫苗剂量、管理库存和规划补货。此外，印度、中国和巴西正在扩大国内疫苗生产，这推动了对国内低温运输产能和合规系统的需求。

推动全球疫苗物流市场向前发展的力量有哪些？

疫苗物流市场的成长受到多种因素的推动，包括全球疫苗接种计画的扩大、对温度敏感型生技药品需求的增加，以及公共和私营部门对低温运输基础设施投资的增加。新冠疫情带来了模式转移，暴露了全球疫苗分发的脆弱性，并促使人们努力建立更具弹性、更灵活、更可追溯的物流系统。各国政府目前正将低温运输物流计画纳入其疫情防范策略和公共卫生预算，以确保长期需求稳定。

医药创新也是一大驱动力。随着mRNA平台、基于载体的疫苗和新型佐剂製剂的发展，疫苗的温度和处理要求日益复杂。这推动了陆运、空运和海运运输方式对先进包装、被动冷却系统和主动冷藏技术的需求。此外，从世界卫生组织预先认证到国家良好分销规范 (GDP)，越来越多的国际法规正在推动物流供应商加强其品质保证、文件和风险管理实践。

私募股权和创投对医药物流新兴企业的投资，以及全球物流巨头（例如 DHL、UPS、Kuehne+Nagel）扩大其低温运输运力，进一步反映出市场兴趣的日益增长。随着气候变迁、全球健康威胁以及对公平疫苗取得的需求重塑全球卫生格局，市场格局仍将对从城市中心到乡村地区以及介于两者之间的所有地区实现大规模疫苗接种成果至关重要。

部分

服务（运输、仓储、加值）、最终用户（医院、药厂/经销商、其他最终用户）

受访公司范例

  • 3PL-Agility
  • AIT Worldwide Logistics
  • AIT Worldwide Logistics
  • AllCargo Logistics
  • American Airlines Cargo
  • Americold Logistics
  • Biocair
  • CEVA Logistics
  • Cold Chain Technologies
  • DB Schenker
  • DHL Global Forwarding
  • DP World
  • DPD/Deutsche Post AG
  • Dulas Ltd.
  • FedEx Corporation
  • Gebruder Weiss
  • IndoSurgicals Pvt. Ltd.
  • Kuehne+Nagel
  • LifeConEx（DHL subsidiary）
  • Nippon Express

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 没有遵循典型的 LLM 或特定于行业的 SLM查询，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP39474

Global Vaccine Logistics Market to Reach US$3.8 Billion by 2030

The global market for Vaccine Logistics estimated at US$3.0 Billion in the year 2024, is expected to reach US$3.8 Billion by 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Transportation Service, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$2.2 Billion by the end of the analysis period. Growth in the Warehousing Service segment is estimated at 4.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$826.7 Million While China is Forecast to Grow at 7.3% CAGR

The Vaccine Logistics market in the U.S. is estimated at US$826.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$778.9 Million by the year 2030 trailing a CAGR of 7.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 3.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Global Vaccine Logistics Market - Key Trends & Drivers Summarized

What Makes Vaccine Logistics Uniquely Complex Compared to Other Cold Chain Markets?

Vaccine logistics occupies a distinct niche within the cold chain logistics industry, demanding ultra-reliable temperature control, time-sensitive distribution, and regulatory-compliant traceability across geographies. Unlike general pharmaceuticals or perishables, vaccines are biologics with narrow thermal thresholds-often between 2°C and 8°C-and in some cases (like mRNA vaccines) requiring deep-frozen transport at -70°C. These conditions must be maintained continuously through first-mile manufacturing, mid-mile air/sea transport, and last-mile delivery to clinics or immunization centers. Even minor temperature excursions can render vaccines unusable, resulting in health risks, regulatory non-compliance, and financial losses.

COVID-19 vaccine deployment revealed the scale and complexity of vaccine logistics, driving investments in ultra-low temperature freezers, IoT-enabled thermal packaging, and visibility software. Beyond pandemics, routine immunization programs managed by governments, UNICEF, and Gavi require annual delivery of billions of doses to remote and underserved locations. This necessitates specialized packaging (phase-change materials, vacuum insulation panels), passive cooling boxes, and multi-modal coordination. Challenges also include managing reverse logistics for unused or expired doses, ensuring customs clearance efficiency, and coordinating between national immunization programs and global health agencies.

Which Technologies Are Reshaping the Future of Vaccine Transport and Storage?

Vaccine logistics is being transformed by digital supply chain platforms, real-time condition monitoring, and AI-assisted route planning. Connected sensor technologies embedded in vaccine packaging or transport containers monitor temperature, humidity, vibration, and light exposure in real time. These sensors transmit data via Bluetooth or cellular networks to cloud-based dashboards, enabling proactive risk mitigation. Pharmaceutical logistics providers now use AI algorithms to predict bottlenecks, optimize delivery windows, and reroute shipments based on weather or geopolitical disruptions.

Another innovation is the use of drone logistics and electric vehicles (EVs) for last-mile delivery in remote or urban-congested areas. Solar-powered cold boxes and portable vaccine refrigerators are also being deployed in off-grid regions. Data analytics is improving forecasting and inventory planning, reducing both stockouts and vaccine wastage. Blockchain pilots are being explored for tamper-proof tracking of vaccine provenance, batch records, and regulatory audit trails. These digital layers are essential to building trust, especially in international vaccine trade, where regulatory harmonization is often lacking.

Where Is the Demand for Specialized Vaccine Logistics Growing Most Rapidly?

Demand for specialized vaccine logistics is surging across both developed and emerging markets, driven by expanded immunization schedules, adult vaccine uptake, and epidemic preparedness initiatives. In high-income countries, the focus is on building resilient cold chains for seasonal influenza, RSV, shingles, and COVID-19 boosters. These regions are also investing in smart warehousing, temperature-controlled distribution hubs, and API integrations between vaccine manufacturers, distributors, and public health systems.

In low- and middle-income countries (LMICs), the emphasis is on last-mile access, cold chain electrification, and strengthening of public-private logistics partnerships. Global health initiatives-such as COVAX, Gavi’s Cold Chain Equipment Optimization Platform (CCEOP), and PATH’s NextGen cold chain solutions-are driving deployment of solar refrigerators, digital VVMs (vaccine vial monitors), and training for health workers. Countries in Sub-Saharan Africa, Southeast Asia, and Latin America are also adopting national vaccine logistics management systems (vLMIS) to track doses, manage inventories, and plan replenishments. Additionally, domestic vaccine manufacturing growth in India, China, and Brazil is increasing the need for intra-national cold chain capacity and compliance systems.

What Forces Are Powering the Global Vaccine Logistics Market Forward?

The growth in the vaccine logistics market is driven by several factors, including expanded global immunization programs, rising demand for temperature-sensitive biologics, and increasing public and private investment in cold chain infrastructure. COVID-19 created a paradigm shift, exposing vulnerabilities in global vaccine distribution and catalyzing efforts to build more resilient, agile, and traceable logistics systems. National governments are now incorporating cold chain logistics planning into pandemic preparedness strategies and public health budgets, ensuring long-term demand stability.

Pharmaceutical innovation is another driver. With the growth of mRNA platforms, vector-based vaccines, and novel adjuvanted formulations, the temperature and handling requirements of vaccines are becoming more complex. This is stimulating demand for advanced packaging, passive cooling systems, and active reefer technologies across land, air, and sea modes. Moreover, international regulatory tightening-from WHO prequalification to national Good Distribution Practices (GDP)-is pushing logistics providers to enhance quality assurance, documentation, and risk management practices.

Private equity and venture capital investment in pharmaceutical logistics startups, along with global logistics majors expanding cold chain capacity (e.g., DHL, UPS, Kuehne+Nagel), further reflect growing market interest. As climate change, global health threats, and demand for equitable vaccine access reshape the global health landscape, the vaccine logistics market will remain central to delivering immunization outcomes at scale-across urban centers, rural outposts, and everything in between.

SCOPE OF STUDY:

The report analyzes the Vaccine Logistics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Service (Transportation Service, Warehousing Service, Value-Added Services); End-User (Hospitals End-User, Drug Manufacturers & Distributors End-User, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • 3PL-Agility
  • AIT Worldwide Logistics
  • AIT Worldwide Logistics
  • AllCargo Logistics
  • American Airlines Cargo
  • Americold Logistics
  • Biocair
  • CEVA Logistics
  • Cold Chain Technologies
  • DB Schenker
  • DHL Global Forwarding
  • DP World
  • DPD/Deutsche Post AG
  • Dulas Ltd.
  • FedEx Corporation
  • Gebruder Weiss
  • IndoSurgicals Pvt. Ltd.
  • Kuehne+Nagel
  • LifeConEx (DHL subsidiary)
  • Nippon Express

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Vaccine Logistics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Global Vaccination Campaigns Throw the Spotlight on Scalable and Resilient Vaccine Logistics Infrastructure
    • Expansion of Cold Chain Networks Spurs Growth in Temperature-Controlled Storage and Transportation Solutions
    • Rising Demand for Last-Mile Delivery Efficiency Expands Addressable Market for Specialized Vaccine Distribution Services
    • Innovation in Temperature Monitoring and IoT Integration Strengthens the Business Case for Smart Vaccine Logistics
    • Increasing Use of mRNA and Biologic Vaccines Drives Adoption of Ultra-Cold Chain Logistics Technologies
    • Emerging Markets Push for Immunization Equity Fuels Investment in Rural and Remote Area Distribution Capabilities
    • Integration with National Immunization Programs Enhances Demand Forecasting and Inventory Management Systems
    • Growth in Outsourcing by Pharma Companies Supports Expansion of Specialized Vaccine Logistics Providers
    • Standardization of Packaging, Labeling, and Handling Protocols Improves Cross-Border Vaccine Movement
    • Real-Time Visibility and Exception Management Tools Improve Cold Chain Integrity and Risk Mitigation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Vaccine Logistics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Vaccine Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Vaccine Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Vaccine Logistics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Transportation Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Transportation Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Transportation Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Warehousing Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Warehousing Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Warehousing Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Value-Added Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Value-Added Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Value-Added Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospitals End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Drug Manufacturers & Distributors End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Drug Manufacturers & Distributors End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Drug Manufacturers & Distributors End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • JAPAN
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • CHINA
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: China 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: China 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • EUROPE
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Vaccine Logistics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Vaccine Logistics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Vaccine Logistics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • FRANCE
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: France 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: France 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • GERMANY
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Logistics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Vaccine Logistics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Vaccine Logistics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • INDIA
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: India 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: India 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Vaccine Logistics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Vaccine Logistics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Vaccine Logistics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Vaccine Logistics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Vaccine Logistics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Vaccine Logistics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • AFRICA
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030

IV. COMPETITION